Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2016 Filed Sep 14, 2016 21:53 UTC |
GARRISON J. BARRETTEVP, CFO
|
GrantEmployee Stock Options (right to buy) · Derivative | 450,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001209191-16-141461 · doc4.xml · derivative · entry 1 GARRISON J. BARRETT · CIK 0001684694 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-09-12 F1 · security: Grant of employee stock options (right to buy) to purchase shares of Issuer's common stock (the "Options"). The Options were granted pursuant to Issuer's 2011 Amended and Restated Equity Incentive Plan. Such Shares were issued as part of Reporting Person's compensation as described in his employment agreement. F2 · derivative.exercise_date: The Options vest over a three year period: 150,000 Options vest on September 12, 2017. Thereafter, 12,500 Options vest monthly for two years. The Options will be fully vested as of September 12, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.